Payload Information
General Information of This Payload
| Payload ID | PAY0XZAUT |
|||||
|---|---|---|---|---|---|---|
| Name | MH30010008 |
|||||
| Target(s) | DNA topoisomerase 1 (TOP1) | |||||
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
MHB-036C [Phase 1/2]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05642949 | Phase Status | Phase 1/2 | ||
| Clinical Description |
Phase 1/2, multi-center, open-label, dose escalation and cohort expansion study to evaluate the safety/tolerability, pharmacokinetics and efficacy of MHB036C in participants with advanced or metastatic solid tumors.
|
||||
References